CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 84 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,536 | +135.9% | 3,448 | +43.0% | 0.00% | – |
| Q2 2023 | $43,461 | +441.3% | 2,412 | +382.4% | 0.00% | – |
| Q1 2023 | $8,029 | +100.7% | 500 | +96.1% | 0.00% | – |
| Q4 2022 | $4,000 | -20.0% | 255 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 255 | +10.9% | 0.00% | – |
| Q2 2022 | $4,000 | -84.6% | 230 | -80.0% | 0.00% | – |
| Q1 2022 | $26,000 | -40.9% | 1,150 | -24.6% | 0.00% | – |
| Q4 2021 | $44,000 | +41.9% | 1,525 | +5.2% | 0.00% | – |
| Q3 2021 | $31,000 | +14.8% | 1,450 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | +285.7% | 1,450 | +222.2% | 0.00% | – |
| Q1 2021 | $7,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |